within Pharmacolibrary.Drugs.ATC.N;

model N05CH02
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.015,
    Cl             = 0.0006483333333333333,
    adminDuration  = 600,
    adminMass      = 8 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0896,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.043166666666666666,
    Tlag           = 10.020000000000001,            
    Vdp             = 0.055,
    k12             = 52.3,
    k21             = 52.3
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N05CH02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Ramelteon is a melatonin receptor agonist used for the treatment of insomnia characterized by difficulty with sleep onset. It is approved for use by regulatory agencies such as the FDA and is currently prescribed in clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters described in healthy adult subjects after a single oral dose.</p><h4>References</h4><ol><li><p>Simpson, D, &amp; Curran, MP (2008). Ramelteon: a review of its use in insomnia. <i>Drugs</i> 68(13) 1901–1919. DOI:<a href=\"https://doi.org/10.2165/00003495-200868130-00011\">10.2165/00003495-200868130-00011</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/18729542/\">https://pubmed.ncbi.nlm.nih.gov/18729542</a></p></li><li><p>Greenblatt, DJ, et al., &amp; Karim, A (2007). Age and gender effects on the pharmacokinetics and pharmacodynamics of ramelteon, a hypnotic agent acting via melatonin receptors MT1 and MT2. <i>Journal of clinical pharmacology</i> 47(4) 485–496. DOI:<a href=\"https://doi.org/10.1177/0091270006298602\">10.1177/0091270006298602</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/17389558/\">https://pubmed.ncbi.nlm.nih.gov/17389558</a></p></li><li><p>Laustsen, G, &amp; Andersen, M (2006). Ramelteon (rozerem) a novel approach for insomnia treatment. <i>The Nurse practitioner</i> 31(4) 52–55. DOI:<a href=\"https://doi.org/10.1097/00006205-200604000-00011\">10.1097/00006205-200604000-00011</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/16607213/\">https://pubmed.ncbi.nlm.nih.gov/16607213</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N05CH02;
